JKJustin J. Kim

Justin J. Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Justin J. Kim has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Complications in patients with midlines compared to peripherally inserted central catheters for outpatient parenteral antimicrobial therapy

    by Justin J. Kim, Guadalupe Ordaz-Nielsen, James B. Vu, Kim L. Tran, Ho D. Kim, Michael Schoeny, Michael Y. Lin

    In this single-center, retrospective cohort study of 1169 patients requiring outpatient parenteral antimicrobial therapy, complications (i.e., bloodstream infections or venous thrombosis) occurred more frequently in patients with midlines (6.4 per 1,000 line-days) than peripherally inserted central catheters (1.1 per 1,000 line-days), adjusted hazard ratio 3.60 (95% confidence interval 1.66–7.81).

  • Improving the Severity Classification System of Diabetes-Related Foot Infections: Necrosis is a Better Predictor of Amputation Than Systemic Inflammatory Response

    by Justin J. Kim, Jennifer Fernandez, Ho D. Kim, Kelli J. McConnehey, Brian M. Schmidt

    Background. The International Working Group on the Diabetic Foot (IWGDF)/Infectious Disease Society of America (IDSA) classification system of diabetes-related foot infection (DFI) severity requires a severe infection to have the systemic inflammatory response syndrome (SIRS). Subsequent attempts to improve this classification system to include other clinically relevant characteristics (eg, necrosis and osteomyelitis) have not reliably predicted patient outcomes such as amputation. The purpose of this study was to propose an improved classification system based on clinically relevant predictors of amputation at our institution. Methods. This was a single-center, retrospective cohort study of 270 unique patients with 346 DFIs. We determined the association between clinical characteristics of each DFI (eg, cellulitis, abscess, necrosis, osteomyelitis, and SIRS) and amputation within 90 days of presentation. We derived a new severity classification system based on the presence of necrosis and compared the performance of this classification system to the IWGDF/IDSA classification system. Results. Our “necrosis classification system” predicted that mild, moderate, and severe DFI had a 20% (95% confidence interval [CI] 2%, 38%), 40% (95% CI [33%, 47%]), and 74% (95% CI [64%, 84%]) risk of amputation within 90 days of presentation, respectively, and discriminated between moderate and mild, and severe and moderate DFI. The IWGDF/IDSA classification system predicted that mild, moderate, and severe DFI had a 29% (95% CI [9%, 49%]), 43% (95% CI [36%, 50%]), and 54% (95% CI [44%, 63%]) risk of amputation within 90 days of presentation, respectively, and did not discriminate between moderate and mild, or severe and moderate DFI. Conclusion. This necrosis classification system discriminated the risk of amputation at 90 days better than the IWGDF/IDSA classification system. Our new classification system may have greater clinical relevance but needs to be validated to confirm its generalizability. Level of evidence: Level III: Retrospective comparative study

  • Open Access

    A data-driven financial justification for an outpatient infectious diseases pharmacist

    by Justin J. Kim, Laura N. Hernandez Guarin, Jonathan Contreras, Mary K. Hayden, Sarah Y. Won

    We present a financial justification for an outpatient infectious diseases pharmacist, based on cost savings from decreases in length of stay for patients with Staphylococcus aureus infections and additional revenue generated by physicians and pharmacists while following patients discharged on outpatient parenteral antimicrobial therapy.

  • Open Access

    Predictors of postpandemic preparedness for special pathogens

    by Morgan M. Kuhnly, Caitlin M. Adams Barker, Kathleen O. Stewart, Justin J. Kim

    In this survey of 31 hospitals, large metropolitan facilities had a 9.5-fold odds of reporting preparedness for special pathogens; hospitals with special pathogens teams had a 14.3-fold odds of reporting preparedness for special pathogens. In the postpandemic world, healthcare institutions must invest in special pathogen responses to maximize patient safety.


  • Open Access

    The Effect of Retained Hardware on Failure Among Prosthetic Joint Infections of the Knee in the Presence and Absence of Staphylococcus aureus

    by Justin J Kim, HeeEun Kang, Kathleen O Stewart

    The risk of failure associated with different surgical strategies for prosthetic joint infections (PJIs) among patients with and without Staphylococcus aureus is uncertain. The purpose of this study was to assess whether S. aureus modifies the association between retained hardware and failure following revision surgery for PJI of the knee. This was a single-center retrospective cohort study of 106 first PJIs of the knee between 2016 and 2020 at a rural academic medical center. The exposure was retained hardware following revision surgery for PJI, and the outcomes were recurrent infection, any infection, and a composite outcome including any infection, unplanned revision, failure to undergo reimplantation, amputation, or death within 2 years of revision. We used negative binomial regression to quantify the association between the exposure and outcome and to assess the presence of S. aureus as an effect modifier. Retained hardware was significantly associated with failure when defined as recurrent infection among S. aureus PJI (adjusted risk difference [aRD], 0.38; 95% CI, 0.12–0.64) but not in the absence of S. aureus (aRD, −0.02; 95% CI, −0.17 to 0.13), and S. aureus was an effect modifier (Pinteraction = .01). We report a significant association between the presence of retained hardware and recurrent infection among S. aureus PJI of the knee, but not for non–S. aureus PJI. This could help inform the surgical management of PJI of the knee in cases where the microbiology is known before surgery.

  • Open Access

    A comparison of National Healthcare Safety Network surveillance definitions to physician review for central-line–associated bloodstream infections

    by Justin J. Kim, HeeEun Kang, Asif N. Khan, Rebecca Wang, Stephanie C. Casale, Caitlin M. Adams Barker, Michael S. Calderwood, Kathleen O. Stewart

    For 147 hospital-onset bloodstream infections, we assessed the sensitivity, specificity, positive predictive value, and negative predictive value of the National Healthcare Safety Network surveillance definitions of central-line–associated bloodstream infections against the gold standard of physician review, examining the drivers of discrepancies and related implications for reporting and infection prevention.


  • Open Access

    Investigating potential drivers of increased central-line–associated bloodstream infections during the SARS-CoV-2 omicron-variant surge

    by HeeEun Kang, Kathleen O. Stewart, Asif Khan, Stephanie C. Casale, Caitlin Adams Barker, Justin Kim

    Background: Central-line–associated bloodstream infection (CLABSI) rates increased nationally during COVID-19, the drivers of which are still being characterized in the literature. CLABSI rates doubled during the SARS-CoV-2 omicron-variant surge at our rural academic medical center. We sought to identify potential drivers of CLABSIs by comparing period- and patient-specific characteristics of this COVID-19 surge to a historical control period. Methods: We defined the study period as the time of highest COVID-19 burden at our hospital (July 2021–June 2022) and the control period as the previous 2 years (July 2019–June 2021). We compared NHSN CLABSI standardized infection ratios (SIRs), central-line standardized utilization ratios (SURs), completion of practice evaluation tools (PETs) for monitoring of central-line bundle compliance, and proportions of traveling nurses. We performed chart reviews to determine patient-specific characteristics of NHSN CLABSIs during these periods, including demographics, comorbidities, central-line characteristics and care, and microbiology. Results: The CLABSI SIR was significantly higher during the study period than the control period (0.89 vs 0.52; P = .03); the SUR was significantly higher during the study period (1.08 vs 1.02; P < .01); the PET completion per 100 central-line days was significantly lower during the study period (23.0 vs 31.5; P < .01); and the proportion of traveling nurses was significantly higher during the study period (0.20 vs 0.08; P < .01) (Fig. 1). Patients with NHSN CLABSIs during the study period were more likely to have a history of COVID-19 (27% vs 3%; P = .01) and were more likely to receive a higher level of care (60% vs 27%; P = .02). During the study period, more patients had multilumen catheters (87% vs 61%; P = .04). The type of catheter, catheter care (ie, dressing changes and chlorhexidine bathing), catheter duration before CLABSI, and associated microbiology were similar between the study and control periods (Table 1). Conclusions: During the SARS-CoV-2 omicron-variant surge, the increase in CLABSIs at our hospital was significantly associated with increased central-line utilization, decreased PET completion, and increased proportion of traveling nurses. Critical illness and multilumen catheters were significant patient-specific factors that differed between CLABSIs from the study and control periods. We did not observe differences in catheter type, duration, or catheter care. Our study highlights key modifiable risk factors for CLABSI reduction. These findings may be surrogates for other difficult-to-measure challenges related to the culture of safety during a global pandemic, such as staff education related to infection prevention and daily review of central-line necessity. Disclosures: None

  • National survey study of nirmatrelvir-ritonavir prescribing processes and access barriers during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron surge of the coronavirus disease 2019 (COVID-19) pandemic

    by Rebecca Wang, Michael S. Calderwood, Craig P. Worby, Jose R. Mercado, Justin J. Kim

    In this national survey, we found that individual patient assessments by pharmacists were more common at facilities using centralized prescribing for nirmetralvir-ritonavir (Paxlovid) than decentralized prescribing. Provider discomfort was initially less with centralized prescribing, but later, there was no difference in provider discomfort based on prescribing mechanism.


  • Association between in situ steroids and spine surgical site infections among instrumented procedures

    by James E. Lee, Kathleen O. Stewart, Jessica L. Swain, Evalina Bond, Michael S. Calderwood, Justin J. Kim

    Objective: To estimate the association between in situ steroids and spine surgical-site infections (SSIs), assessing spinal instrumentation as an effect modifier and adjusting for confounders.Design: Case–control study.Setting: Rural academic medical center.Participants: We identified 1,058 adults undergoing posterior fusion and laminectomy procedures as defined by the National Healthcare Safety Network without a pre-existing SSI between January 2020 and December 2021. We identified 26 SSI as cases and randomly selected 104 controls from the remaining patients without SSI.Methods: The primary exposure was the intraoperative administration of methylprednisolone in situ (ie, either in the wound bed or as an epidural injection). The primary outcome was a clinical diagnosis of SSI within 6 months of a patient’s first spine surgery at our facility. We quantified the association between the exposure and outcome using logistic regression, using a product term to assess for effect modification by spinal instrumentation and the change-in-estimate approach to select significant confounders.Results: Adjusting for Charlson comorbidity index and malignancy, in situ steroids were significantly associated with spine SSI relative to no in situ steroids for instrumented procedures (adjusted odds ratio [aOR], 9.93; 95% confidence interval [CI], 1.54–64.0), but they were not associated with spine SSIs among noninstrumented procedures (aOR, 0.86; 95% CI, 0.15–4.93).Conclusions: In situ steroids were significantly associated with spine SSI among instrumented procedures. The benefits of in situ steroids for pain management following spine surgery should be weighed against the risk of SSI, especially for instrumented procedures.